Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Trials|January 17, 2019
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: update to the study protocol for a randomized controlled trialAnne-Laure Couderc, Emilie Nouguerède, Karine Baumstarck, et al.Trials|April 14, 2017
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trialElodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, et al.The Lancet. Healthy Longevity|March 3, 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trialJoël Guigay, Cécile Ortholan, Damien Vansteene, et al.The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized TrialLionnel Geoffrois, Laurent Martin, Dominique De Raucourt, et al.Cancers|July 24, 2021
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study GroupCandice Hober, Lisa Fredeau, Anne Pham-Ledard, et al.Pageof 4